Search

Your search keyword '"Jozwiak, S"' showing total 241 results

Search Constraints

Start Over You searched for: Author "Jozwiak, S" Remove constraint Author: "Jozwiak, S"
241 results on '"Jozwiak, S"'

Search Results

2. Tuberous sclerosis complex-associated neuropsychiatric disorders (TAND): further results from the TOSCA natural history study

3. Quality of life and burden of disease in tuberous sclerosis complex (TSC): findings from TOSCA research project

4. Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell cultures

8. TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex

9. MicroRNA-34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis

10. MicroRNA-34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis

11. Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): New Findings on Age, Sex, and Genotype in Relation to Intellectual Phenotype

12. Renal Manifestations of Tuberous Sclerosis Complex: Key Findings From the Final Analysis of the TOSCA Study Focussing Mainly on Renal Angiomyolipomas

17. Newly diagnosed and growing subependymal giant cell astrocytoma in adults with tuberous sclerosis complex: Results from the International TOSCA Study

18. Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study

20. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

21. Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study.

24. Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience

28. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - Baseline data on 2093 patients

29. Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations

30. Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations

35. Prospective serial neuropsychological study in infants with Tuberous Sclerosis Complex (TSC): First analysis from the EPISTOP Project

36. Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell cultures

37. Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell cultures

42. Immunohistochemical and microscopic studies on giant cells in tuberous sclerosis

44. The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1

50. Genetic diseases and molecular genetics

Catalog

Books, media, physical & digital resources